89 PSA recurrences over median follow-up of 11.3 years

Slides:

Advertisements

Similar presentations

Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA

Advertisements

AB C Breast cancer Gas6 RNA Seq D E F Figure S1. AXL and GAS6 expression correlates with a mesenchymal signature. (A) Scatter plot representing the RNA.

A Metabolomic Approach to the Identification of Cancer Biomarkers

Lyn Tyrosine Kinase Regulates Androgen Receptor Expression and Activity in Castrate Resistant Prostate Cancer Anousheh Zardan, Ka Mun Nip, Daksh Thaper,

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.

Comparative quantitative evaluation of the XIAP, survivin & Ki67 transcript levels in urine & tissue samples of bladder cancer patients.

Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,

Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.

Design of Clinical Trials for Select Patients With a Rising PSA following Primary Therapy Anthony V. D’Amico, MD, PhD Professor of Radiation Oncology Harvard.

Comparative quantitative evaluation of the XIAP, survivin & Ki67 transcript levels in urine & tissue samples of bladder cancer patients Woei-Yun Siow &

Ten Year Outcomes In Men Under 60 Treated With Iodine-125 Permanent Brachytherapy As Monotherapy GU - Prostate Cancer: Novel Imaging (MRI,PET) & Brachytherapy.

Ki67 SPATIAL DISTRIBUTION Ki67 PROLIFERATION REOXYGENATION 48 hours SUPPLEMENTARY FIGURES S1ABC Figure S1. Reoxygenation and Repopulation at 48 hours in.

Poster Title ABSTRACT #59 Cell cycle progression genes differentiate indolent from aggressive prostate cancer. Steven Stone 1 Jack Cuzick 2, Julia Reid.

United States Cancer Statistics 2002 Incidence and Mortality

IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC.

This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in.

#4826 Cancer/testis antigen expression pattern is a potential biomarker for prostate cancer aggressiveness Luciane T. Kagohara1, Prakash Kulkarni1, Takumi.

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,

Volume 179, Issue 2, Pages (February 2008)

miR p Is a Novel Prognostic Biomarker of Prostate Cancer

The PSA Era is not Over for Prostate Cancer

A B C D Figure S3: DiO6(3) staining of mitochondrial networks in primary prostate tumor organ cultures. (A) Epithelial.

A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR- tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal.

Volume 355, Issue 2, Pages (December 2014)

Copyright © 2015 American Medical Association. All rights reserved.

Intervista a Federico Cappuzzo

Tumor Marker Tests.

Volume 139, Issue 6, Pages e12 (December 2010)

Supplementary Figures

a b SUM149PT Motility Invasion C V C V

Apollo Gleneagles Hospitals,

Advances in the Treatment of Metastatic Prostate Cancer

GM-CSF induces tumor cell EMT and stemness.

Volume 184, Issue 4, Pages (October 2010)

Volume 139, Issue 6, Pages e12 (December 2010)

Nat. Rev. Urol. doi: /nrurol

The PSA Era is not Over for Prostate Cancer

Volume 141, Issue 6, Pages (December 2011)

Epithelial-Mesenchymal Transitions

LESLIE M. RAINWATER, M.D., WILLIAM R. MORGAN, M.D.

A B Figure S1 DU145 PC-3 22Rv1 RWPE-1 BPH1 Relative levels

Relative expression ratio Relative expression ratio

Supplementary Figure 1 Non-migrating cells Migrating cells

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,

Figure 1. Non-biochemical recurrence rate for the entire population (n = 122). From: Salvage radiation therapy for prostate cancer patients after prostatectomy.

Mock ICSBP Snail Slug Twist β-actin Suppl. Fig. 1.

Volume 19, Issue 3, Pages (March 2017)

Maxime Janin, Manel Esteller Cell Metabolism

Supplementary figure S2

Endoscopic Submucosal Dissection of Early Cancers, Flat Adenomas, and Submucosal Tumors in the Gastrointestinal Tract Andreas Probst, Daniela Golger,

Supplementary Fig S1, Zembutsu H et al.

Associations between TS, TTF-1, FR-α, FPGS, and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Pemetrexed Plus Carboplatin.

1. Identify the tissue.

Twist: a new link from hypoxia to fibrosis

Supplementary Table S2 Correlation between pre-operative plasma miR-451 or miR-486 concentrations and clinicopathologic features in gastric cancer patients.

PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. A,

MW (kDa) 2 µg 0.5 µg Supplementary Figure S1. SDS-PAGE under reducing condition analysis (Coomassie brilliant blue staining) of.

Targeting eIF4E increases ZEB1 protein and mRNA levels and decreases ZEB1-targeting miR-200c and miR-141 microRNAs. Targeting eIF4E increases ZEB1 protein.

a b 10A.zp85WT 10A.zp85S83μ 10A.vec 10A.z 10A.vec 10Az 10Az.p85WT

AXL is not expressed in human prostate tumors.

VEGF expression in neoplastic and normal prostate tissue.

Histopathology of anal tissue.

Study overview. Study overview. A, Schematic illustrating clinical trial design and the nature and number of tissue specimens available for downstream.

Dual-color FISH analysis of 16p13

BAF57 is highly expressed in human prostate cancer specimens.

Cabozantinib causes significant tumor cell elimination in vivo, but modest apoptosis induction in vitro. Cabozantinib causes significant tumor cell elimination.

Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per men), among Canadian men aged 45 years.

MSCs elicit EMT, invasion of carcinoma cells, and increased tumor initiation of xenografts. MSCs elicit EMT, invasion of carcinoma cells, and increased.

Presentation transcript:

205 evaluable men with localized PC treated with RP at the Durham VAMC and available TMA tissue 89 PSA recurrences over median follow-up of 11.3 years 71 deaths over median follow-up of 11.3 years 3 deaths due to prostate cancer Exclusions due to unevaluable tissue due to lack of tumor in TMA specimen: Ki-67: 41 SNAIL: 17 ZEB1: 16 Vimentin: 2 E/N-cadherin: 0 TWIST: n=57 Biomarker evaluable populations: Ki-67 n=164 SNAIL n=188 ZEB1 n=189 Vimentin n=203 E/N-cadherin n=205 TWIST n=148 Supplementary Figure 1. REMARK algorithm for handling of tissues and biomarkers in this study.